CDKN1A and liposarcoma: We found that selinexor increased the expression p53 and its target genes (e.g., p21 and BAX) proteins in LPS141 liposarcoma cells (MDM2 amplification) without altering the expression of MDM2 (Figure 3B and Supplementary Figure S5A).